Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection
Aim. To perform comparative analysis of visceral sensitivity index (VSI) of patients with previously diagnosed irritable bowel syndrome (IBS) and of patients with IBS symptoms after COVID-19 infection. Materials and methods. The study was carried out on the basis of University Clinical Hospital №...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ZAO "Consilium Medicum"
2022-07-01
|
| Series: | Consilium Medicum |
| Subjects: | |
| Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/109390/pdf |
| _version_ | 1811180265664413696 |
|---|---|
| author | Iana Yu. Feklina Marina G. Mnatsakanyan Alexander P. Pogromov Olga V. Tashchyаn |
| author_facet | Iana Yu. Feklina Marina G. Mnatsakanyan Alexander P. Pogromov Olga V. Tashchyаn |
| author_sort | Iana Yu. Feklina |
| collection | DOAJ |
| description | Aim. To perform comparative analysis of visceral sensitivity index (VSI) of patients with previously diagnosed irritable bowel syndrome (IBS) and of patients with IBS symptoms after COVID-19 infection.
Materials and methods. The study was carried out on the basis of University Clinical Hospital №1; 200 patients with COVID-19 infection were examined. Selection criteria were the recommendations of the Rome Consensus IV (2016). Fourteen patients met the criteria for IBS (Rome IV). Forty patients with a verified diagnosis of IBS before the COVID-19 pandemic (Group 2) were selected as a comparison group. The control group included 50 healthy respondents (group 3). Group 1 included 14 patients; Group 2 included 40 patients (54 patients in total): 37 women and 17 men. The control group included 50 patients: 23 men and 27 women. VSI was estimated in the studied groups.
Results. No statistically significant difference of VSI index (p0.05) was revealed while comparing two studied groups (group 1 and group 2). In group 1 and group 2 the mean values of VSI were 24.575.47 and 33.982.55 respectively. Absence of significant differences allows to assume from the position of biopsychosocial model that the patients were initially predisposed to IBS development.
Conclusion. A new coronavirus infection is one of the triggers for the development of IBS 6 months after COVID-19 infection. |
| first_indexed | 2024-04-11T06:47:28Z |
| format | Article |
| id | doaj.art-df8d52ec6ff14838b47c3764802004eb |
| institution | Directory Open Access Journal |
| issn | 2075-1753 2542-2170 |
| language | Russian |
| last_indexed | 2024-04-11T06:47:28Z |
| publishDate | 2022-07-01 |
| publisher | ZAO "Consilium Medicum" |
| record_format | Article |
| series | Consilium Medicum |
| spelling | doaj.art-df8d52ec6ff14838b47c3764802004eb2022-12-22T04:39:19ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702022-07-0124533934210.26442/20751753.2022.5.2017974583Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infectionIana Yu. Feklina0https://orcid.org/0000-0003-2344-1629Marina G. Mnatsakanyan1https://orcid.org/0000-0001-9337-7453Alexander P. Pogromov2https://orcid.org/0000-0002-7426-4055Olga V. Tashchyаn3https://orcid.org/0000-0001-6759-6820Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Aim. To perform comparative analysis of visceral sensitivity index (VSI) of patients with previously diagnosed irritable bowel syndrome (IBS) and of patients with IBS symptoms after COVID-19 infection. Materials and methods. The study was carried out on the basis of University Clinical Hospital №1; 200 patients with COVID-19 infection were examined. Selection criteria were the recommendations of the Rome Consensus IV (2016). Fourteen patients met the criteria for IBS (Rome IV). Forty patients with a verified diagnosis of IBS before the COVID-19 pandemic (Group 2) were selected as a comparison group. The control group included 50 healthy respondents (group 3). Group 1 included 14 patients; Group 2 included 40 patients (54 patients in total): 37 women and 17 men. The control group included 50 patients: 23 men and 27 women. VSI was estimated in the studied groups. Results. No statistically significant difference of VSI index (p0.05) was revealed while comparing two studied groups (group 1 and group 2). In group 1 and group 2 the mean values of VSI were 24.575.47 and 33.982.55 respectively. Absence of significant differences allows to assume from the position of biopsychosocial model that the patients were initially predisposed to IBS development. Conclusion. A new coronavirus infection is one of the triggers for the development of IBS 6 months after COVID-19 infection.https://consilium.orscience.ru/2075-1753/article/viewFile/109390/pdfirritable bowel syndromecovid-19diarrheaconstipationvisceral sensitivity index |
| spellingShingle | Iana Yu. Feklina Marina G. Mnatsakanyan Alexander P. Pogromov Olga V. Tashchyаn Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection Consilium Medicum irritable bowel syndrome covid-19 diarrhea constipation visceral sensitivity index |
| title | Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
| title_full | Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
| title_fullStr | Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
| title_full_unstemmed | Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
| title_short | Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
| title_sort | visceral sensitivity index of patients with irritable bowel syndrome after covid 19 infection |
| topic | irritable bowel syndrome covid-19 diarrhea constipation visceral sensitivity index |
| url | https://consilium.orscience.ru/2075-1753/article/viewFile/109390/pdf |
| work_keys_str_mv | AT ianayufeklina visceralsensitivityindexofpatientswithirritablebowelsyndromeaftercovid19infection AT marinagmnatsakanyan visceralsensitivityindexofpatientswithirritablebowelsyndromeaftercovid19infection AT alexanderppogromov visceralsensitivityindexofpatientswithirritablebowelsyndromeaftercovid19infection AT olgavtashchyan visceralsensitivityindexofpatientswithirritablebowelsyndromeaftercovid19infection |